Top Pharma Giants Rake in Huge Profits and Lavish Investors While Hiking Drug Prices
for their most commonly used insulin products earlier this year, they have benefited from decades of price gouging.
"Pharma executives' claims that research and development expenses drive costs remain unconvincing," Zelnick added,"when those costs are often eclipsed by billions of dollars in handouts to a small group of wealthy investors."that gives Medicare the authority to negotiate the prices of a small number of high-cost medications directly with drugmakers.
Argentina Últimas Noticias, Argentina Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Big Pharma Bets Big on ChinaDespite growing geopolitical risk, Western drugmakers are staying put in China—and that isn’t only down to the size of its market
Leer más »
Pharma lobbying for weight loss drugs could soon pay offThere is still one milestone the companies have yet to reach: passing a bill that would reverse the long-standing ban on Medicare covering obesity drugs, which has floundered for 10 years. Here's more.
Leer más »
SF Giants swept by last-place Nationals, limp away from nation’s capitalOutscored 21-5 over the three-game series, the Giants don’t have a hit with runners in scoring position since Wednesday.
Leer más »
Ottis Anderson fears Saquon Barkley didn’t make correct Giants decision: ‘Wish him luck’Ottis Anderson can’t be convinced that Barkley made the right choice in not accepting the Giants’ latest offer, an offer now past its expiration date.
Leer más »
Skidding Giants return to Detroit for makeup game with TigersWhen the San Francisco Giants made a mid-April visit to Detroit, they weren't expecting to return.
Leer más »
Darnay Holmes, Cor’Dale Flott embracing ‘open competition’ for Giants’ nickel corner jobDarnay Holmes, 25, made one of the biggest plays of last season, but Cor’Dale Flott was drafted by the current regime to play in the slot.
Leer más »